The choice of D-cycloserine was informed by previous findings that this compound showed preclinical benefits in Neuroligin 1 KO mice (human autism and mental retardation) [64] and Tourette syndrome with accompanying ADHD and/or OCD [65]. This evidence concerns the gene NLGN1 and Tourette syndrome.